Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty

Marcin Misztal1, Katarzyna Stopyra, Andrzej Gackowski

  • 1Coronary Artery Disease Department, Institute of Cardiology, Jagiellonian University, Kraków, Poland. mamis@interia.pl

Cardiology Journal
|September 16, 2009
PubMed

Insights

Diastolic heart failure is common after ST-elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI). Left ventricle diastolic dysfunction persists for months, influenced by reperfusion, inflammation, and infarct size.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Internal Medicine

Background:

  • Diastolic heart failure affects over 5% of patients over 65, often with preserved systolic function.
  • Diastolic heart failure presents a significant clinical and epidemiological challenge.
  • Left ventricular diastolic dysfunction is increasingly recognized in heart failure patients.

Purpose of the Study:

  • To investigate the prevalence and influencing factors of left ventricle diastolic dysfunction after primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients.
  • To analyze the relationship between diastolic dysfunction and atherosclerosis risk factors, cardiac biomarkers, and reperfusion parameters.

Main Methods:

  • Prospective study of 99 STEMI patients undergoing primary PCI.
  • Serial evaluations at 24 hours, 7 days, and 3 months post-PCI.
  • Analysis of diastolic dysfunction severity, cardiac biomarkers (troponin I, CPK, CK-MB), CRP levels, and reperfusion parameters (TIMI, TMPG).

Main Results:

  • Left ventricle diastolic dysfunction was prevalent in most STEMI patients within 24 hours post-PCI, persisting at 3 months.
  • Higher cardiac biomarker levels (troponin I, CPK, CK-MB) were associated with restrictive filling patterns.
  • Inflammatory response (CRP levels) and infarct extension significantly correlated with diastolic abnormalities.

Conclusions:

  • Left ventricle diastolic dysfunction is common in STEMI patients post-PCI and remains present long-term.
  • Reperfusion time/effectiveness, inflammatory markers, cardiac biomarkers, and ejection fraction influence diastolic dysfunction development.
  • Infarct size is a significant contributor to the progression of diastolic dysfunction.
Abstract